|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 1 to 100 out of 505 for Igfbp2

<< First    < Previous  |  Next >    Last >>
0.056s
Type Details Score
Gene
Type: gene
Organism: Homo sapiens
Gene
Type: gene
Organism: Rattus norvegicus
Protein Coding Gene
Type: protein_coding_gene
Organism: Mus musculus
Publication
First Author: Wang Y
Year: 2018
Journal: Proc Natl Acad Sci U S A
Title: Pulmonary alveolar type I cell population consists of two distinct subtypes that differ in cell fate.
Volume: 115
Issue: 10
Pages: 2407-2412
Allele
Name: insulin-like growth factor binding protein 2; endonuclease-mediated mutation 1, Nan Tang
Allele Type: Endonuclease-mediated
Attribute String: Inducible, Recombinase
Publication categories: ProxyCollection
Strain
Attribute String: congenic, endonuclease-mediated mutation, mutant strain
Publication
First Author: Khan S
Year: 2019
Journal: Adv Sci (Weinh)
Title: IGFBP2 Plays an Essential Role in Cognitive Development during Early Life.
Volume: 6
Issue: 23
Pages: 1901152
Publication
First Author: Kammel A
Year: 2016
Journal: Hum Mol Genet
Title: Early hypermethylation of hepatic Igfbp2 results in its reduced expression preceding fatty liver in mice.
Volume: 25
Issue: 12
Pages: 2588-2599
Publication  
First Author: Shen F
Year: 2019
Journal: Brain Res
Title: IGFBP2 promotes neural stem cell maintenance and proliferation differentially associated with glioblastoma subtypes.
Volume: 1704
Pages: 174-186
Publication
First Author: Phillips LM
Year: 2016
Journal: J Pathol
Title: Glioma progression is mediated by an addiction to aberrant IGFBP2 expression and can be blocked using anti-IGFBP2 strategies.
Volume: 239
Issue: 3
Pages: 355-64
Publication
First Author: Neumann UH
Year: 2014
Journal: Endocrinology
Title: IGFBP2 is neither sufficient nor necessary for the physiological actions of leptin on glucose homeostasis in male ob/ob mice.
Volume: 155
Issue: 3
Pages: 716-25
GXD Expression  
Probe: MGI:4442777
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Ambiguous
Sex: Not Specified
Emaps: EMAPS:3271120
Pattern: Not Specified
Stage: TS20
Assay Id: MGI:4450871
Age: embryonic day 12.5
Image: Igfbp2 - E12.5
Note: Staining is either absent or ubiquitous in the postmitotic neurons in the cortical plate of the cerebral cortex.
Specimen Num: 2
GXD Expression
Probe: MGI:4442777
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Moderate
Sex: Not Specified
Emaps: EMAPS:3271122
Pattern: Scattered
Stage: TS22
Assay Id: MGI:4450871
Age: embryonic day 14.5
Image: Igfbp2 - E14.5
Note: There is moderate, scattered staining in the postmitotic neurons in the cortical plate of the cerebral cortex.
Detected: true
Specimen Num: 3
GXD Expression  
Probe: MGI:4442777
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Ambiguous
Sex: Not Specified
Emaps: EMAPS:3271124
Pattern: Not Specified
Stage: TS24
Assay Id: MGI:4450871
Age: embryonic day 16.5
Image: Igfbp2 - E16.5
Note: Staining is either absent or ubiquitous in the postmitotic neurons in the cortical plate of the cerebral cortex.
Specimen Num: 4
GXD Expression  
Probe: MGI:4442777
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Ambiguous
Sex: Not Specified
Emaps: EMAPS:3271220
Pattern: Not Specified
Stage: TS20
Assay Id: MGI:4450871
Age: embryonic day 12.5
Image: Igfbp2 - E12.5
Note: Staining is either absent or ubiquitous in the postmitotic neurons in the intermediate zone of the cerebral cortex.
Specimen Num: 2
GXD Expression
Probe: MGI:4442777
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Moderate
Sex: Not Specified
Emaps: EMAPS:3271222
Pattern: Scattered
Stage: TS22
Assay Id: MGI:4450871
Age: embryonic day 14.5
Image: Igfbp2 - E14.5
Note: There is moderate, scattered staining in the postmitotic neurons in the intermediate zone of the cerebral cortex.
Detected: true
Specimen Num: 3
GXD Expression  
Probe: MGI:4442777
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Ambiguous
Sex: Not Specified
Emaps: EMAPS:3271224
Pattern: Not Specified
Stage: TS24
Assay Id: MGI:4450871
Age: embryonic day 16.5
Image: Igfbp2 - E16.5
Note: Staining is either absent or ubiquitous in the postmitotic neurons in the intermediate zone of the cerebral cortex.
Specimen Num: 4
GXD Expression
Probe: MGI:4442777
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Moderate
Sex: Not Specified
Emaps: EMAPS:1754320
Pattern: Non-Uniform
Stage: TS20
Assay Id: MGI:4450871
Age: embryonic day 12.5
Image: Igfbp2 - E12.5
Note: There is moderate, scattered staining in the ventricular zone of the dorsal thalamus and weak, scattered staining in the prethalamus.
Detected: true
Specimen Num: 2
GXD Expression
Probe: MGI:4442777
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Strong
Sex: Not Specified
Emaps: EMAPS:1754322
Pattern: Not Specified
Stage: TS22
Assay Id: MGI:4450871
Age: embryonic day 14.5
Image: Igfbp2 - E14.5
Note: There is strong staining in the ventricular zone of the dorsal thalamus and prethalamus.
Detected: true
Specimen Num: 3
GXD Expression
Probe: MGI:4442777
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Very strong
Sex: Not Specified
Emaps: EMAPS:1754324
Pattern: Not Specified
Stage: TS24
Assay Id: MGI:4450871
Age: embryonic day 16.5
Image: Igfbp2 - E16.5
Note: There is very strong staining in the ventricular zone of the dorsal thalamus and prethalamus.
Detected: true
Specimen Num: 4
GXD Expression
Probe: MGI:4442777
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Moderate
Sex: Not Specified
Emaps: EMAPS:1753720
Pattern: Non-Uniform
Stage: TS20
Assay Id: MGI:4450871
Age: embryonic day 12.5
Image: Igfbp2 - E12.5
Note: There is moderate, scattered staining in the mantle zone of the AVH. Staining is either absent or ubiquitous in the mantle zone of the dorsal and ventral POAs, the PVH, VMH and ARH nuclei and anterior and posterior IDs.
Detected: true
Specimen Num: 2
GXD Expression  
Probe: MGI:4442777
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Ambiguous
Sex: Not Specified
Emaps: EMAPS:1753722
Pattern: Not Specified
Stage: TS22
Assay Id: MGI:4450871
Age: embryonic day 14.5
Image: Igfbp2 - E14.5
Note: Staining is either absent or ubiquitous in the mantle zone of the dorsal and ventral POAs, the PVH, VMH and ARH nuclei, the AVH and anterior and posterior IDs.
Specimen Num: 3
GXD Expression  
Probe: MGI:4442777
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Ambiguous
Sex: Not Specified
Emaps: EMAPS:1753724
Pattern: Not Specified
Stage: TS24
Assay Id: MGI:4450871
Age: embryonic day 16.5
Image: Igfbp2 - E16.5
Note: Staining is either absent or ubiquitous in the mantle zone of the dorsal and ventral POAs, the PVH, SCH, DMH, VMH and ARH nuclei, the AVH, the DAH and the PH.
Specimen Num: 4
GXD Expression
Probe: MGI:4442777
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Moderate
Sex: Not Specified
Emaps: EMAPS:1691319
Pattern: Non-Uniform
Stage: TS19
Assay Id: MGI:4450871
Age: embryonic day 11.5
Image: Igfbp2 - E11.5
Note: There is moderate, scattered staining in the ventricular zone of the cerebral cortex. Staining is either absent or ubiquitous in the ventricular zone of the ganglionic eminences.
Detected: true
Specimen Num: 1
GXD Expression
Probe: MGI:4442777
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Weak
Sex: Not Specified
Emaps: EMAPS:3271820
Pattern: Non-Uniform
Stage: TS20
Assay Id: MGI:4450871
Age: embryonic day 12.5
Image: Igfbp2 - E12.5
Note: There is weak, scattered staining in the mantle zone of the mam and supramam zones. Staining is either absent or ubiquitous in the mantle zone of the premam zone and the TT.
Detected: true
Specimen Num: 2
GXD Expression  
Probe: MGI:4442777
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Ambiguous
Sex: Not Specified
Emaps: EMAPS:3271822
Pattern: Not Specified
Stage: TS22
Assay Id: MGI:4450871
Age: embryonic day 14.5
Image: Igfbp2 - E14.5
Note: Staining is either absent or ubiquitous in the mantle zone of the premam, mam and supramam zones and the TT.
Specimen Num: 3
GXD Expression
Probe: MGI:4442777
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Weak
Sex: Not Specified
Emaps: EMAPS:3271824
Pattern: Non-Uniform
Stage: TS24
Assay Id: MGI:4450871
Age: embryonic day 16.5
Image: Igfbp2 - E16.5
Note: There is weak, scattered staining in the mantle zone of the mam zone. Staining is either absent or ubiquitous in the mantle zone of the premam and supramam zones.
Detected: true
Specimen Num: 4
GXD Expression
Probe: MGI:4442777
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Strong
Sex: Not Specified
Emaps: EMAPS:1690819
Pattern: Non-Uniform
Stage: TS19
Assay Id: MGI:4450871
Age: embryonic day 11.5
Image: Igfbp2 - E11.5
Note: Staining is strong in the PVH & VMH nuclei & premam & mam zones, strong in dorsal & ventral POAs, ARH nucleus & AVH, moderate in dorsal thalamus & prethalamus & absent or ubiquitous in anterior & posterior IDs, TT & supramam zone; some is scattered.
Detected: true
Specimen Num: 1
GXD Expression
Probe: MGI:4442777
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Strong
Sex: Not Specified
Emaps: EMAPS:1753920
Pattern: Non-Uniform
Stage: TS20
Assay Id: MGI:4450871
Age: embryonic day 12.5
Image: Igfbp2 - E12.5
Note: Staining is strong in the VZ of the ventral POA & VMH nucleus, strong & scattered in the ARH nucleus & weak & scattered in the dorsal POA & anterior & posterior IDs. Staining is either absent or ubiquitous in the VZ of the PVH nucleus & the AVH.
Detected: true
Specimen Num: 2
GXD Expression
Probe: MGI:4442777
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Strong
Sex: Not Specified
Emaps: EMAPS:1753922
Pattern: Non-Uniform
Stage: TS22
Assay Id: MGI:4450871
Age: embryonic day 14.5
Image: Igfbp2 - E14.5
Note: There is strong staining in the VZ of the ARH nucleus and moderate staining in the ventral POA and the AVH. Staining is either absent or ubiquitous in the VZ of the dorsal POA, the PVH and VMH nuclei and anterior and posterior IDs.
Detected: true
Specimen Num: 3
GXD Expression
Probe: MGI:4442777
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Strong
Sex: Not Specified
Emaps: EMAPS:1753924
Pattern: Non-Uniform
Stage: TS24
Assay Id: MGI:4450871
Age: embryonic day 16.5
Image: Igfbp2 - E16.5
Note: There is strong staining in the VZ of the ARH nucleus and moderate staining in the ventral POA and the AVH. Staining is either absent or ubiquitous in the VZ of the dorsal POA, the PVH, SCH, DMH and VMH nuclei, the DAH and the PH.
Detected: true
Specimen Num: 4
GXD Expression  
Probe: MGI:4442777
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Ambiguous
Sex: Not Specified
Emaps: EMAPS:1691119
Pattern: Not Specified
Stage: TS19
Assay Id: MGI:4450871
Age: embryonic day 11.5
Image: Igfbp2 - E11.5
Note: Staining is either absent or ubiquitous in the postmitotic neurons in the intermediate zone and cortical plate of the cerebral cortex and in the mantle zone of the ganglionic eminences.
Specimen Num: 1
GXD Expression
Probe: MGI:4442777
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Very strong
Sex: Not Specified
Emaps: EMAPS:1754720
Pattern: Not Specified
Stage: TS20
Assay Id: MGI:4450871
Age: embryonic day 12.5
Image: Igfbp2 - E12.5
Note: There is very strong staining in the ventricular zone of the cerebral cortex.
Detected: true
Specimen Num: 2
GXD Expression
Probe: MGI:4442777
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Strong
Sex: Not Specified
Emaps: EMAPS:1754722
Pattern: Not Specified
Stage: TS22
Assay Id: MGI:4450871
Age: embryonic day 14.5
Image: Igfbp2 - E14.5
Note: There is strong staining in the ventricular zone of the cerebral cortex.
Detected: true
Specimen Num: 3
GXD Expression
Probe: MGI:4442777
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Very strong
Sex: Not Specified
Emaps: EMAPS:1754724
Pattern: Not Specified
Stage: TS24
Assay Id: MGI:4450871
Age: embryonic day 16.5
Image: Igfbp2 - E16.5
Note: There is very strong staining in the ventricular zone of the cerebral cortex.
Detected: true
Specimen Num: 4
GXD Expression
Probe: MGI:4442777
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Strong
Sex: Not Specified
Emaps: EMAPS:3271020
Pattern: Non-Uniform
Stage: TS20
Assay Id: MGI:4450871
Age: embryonic day 12.5
Image: Igfbp2 - E12.5
Note: There is strong staining in the ventricular zone of the premam and mam zones and weak, scattered staining in the TT. Staining is either absent or ubiquitous in the ventricular zone of the supramam zone.
Detected: true
Specimen Num: 2
GXD Expression
Probe: MGI:4442777
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Strong
Sex: Not Specified
Emaps: EMAPS:3271022
Pattern: Non-Uniform
Stage: TS22
Assay Id: MGI:4450871
Age: embryonic day 14.5
Image: Igfbp2 - E14.5
Note: There is strong staining in the ventricular zone of the mam zone. Staining is either absent or ubiquitous in the ventricular zone of the premam and supramam zones and the TT.
Detected: true
Specimen Num: 3
GXD Expression
Probe: MGI:4442777
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Very strong
Sex: Not Specified
Emaps: EMAPS:3271024
Pattern: Non-Uniform
Stage: TS24
Assay Id: MGI:4450871
Age: embryonic day 16.5
Image: Igfbp2 - E16.5
Note: There is very strong staining in the ventricular zone of the mam zone. Staining is either absent or ubiquitous in the ventricular zone of the premam and supramam zones.
Detected: true
Specimen Num: 4
GXD Expression
Probe: MGI:4442777
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Weak
Sex: Not Specified
Emaps: EMAPS:3266520
Pattern: Scattered
Stage: TS20
Assay Id: MGI:4450871
Age: embryonic day 12.5
Image: Igfbp2 - E12.5
Note: There is weak, scattered staining in the ventricular and mantle zones of the ganglionic eminences.
Detected: true
Specimen Num: 2
GXD Expression
Probe: MGI:4442777
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Weak
Sex: Not Specified
Emaps: EMAPS:3266522
Pattern: Scattered
Stage: TS22
Assay Id: MGI:4450871
Age: embryonic day 14.5
Image: Igfbp2 - E14.5
Note: There is weak, scattered staining in the ventricular and mantle zones of the ganglionic eminences.
Detected: true
Specimen Num: 3
GXD Expression  
Probe: MGI:4442777
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Ambiguous
Sex: Not Specified
Emaps: EMAPS:3266524
Pattern: Not Specified
Stage: TS24
Assay Id: MGI:4450871
Age: embryonic day 16.5
Image: Igfbp2 - E16.5
Note: Staining is either absent or ubiquitous in the ventricular and mantle zones of the ganglionic eminences.
Specimen Num: 4
GXD Expression  
Probe: MGI:4442777
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Ambiguous
Sex: Not Specified
Emaps: EMAPS:1690619
Pattern: Not Specified
Stage: TS19
Assay Id: MGI:4450871
Age: embryonic day 11.5
Image: Igfbp2 - E11.5
Note: Staining is either absent or ubiquitous in the mantle zone of the dorsal thalamus, prethalamus, dorsal and ventral POAs, the PVH, VMH and ARH nuclei, the AVH, the anterior and posterior IDs, the premam, mam and supramam zones and the TT.
Specimen Num: 1
GXD Expression
Probe: MGI:4442777
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Moderate
Sex: Not Specified
Emaps: EMAPS:1754120
Pattern: Non-Uniform
Stage: TS20
Assay Id: MGI:4450871
Age: embryonic day 12.5
Image: Igfbp2 - E12.5
Note: There is moderate, scattered staining in the mantle zone of the dorsal thalamus. Staining is either absent or ubiquitous in the mantle zone of the prethalamus.
Detected: true
Specimen Num: 2
GXD Expression
Probe: MGI:4442777
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Weak
Sex: Not Specified
Emaps: EMAPS:1754122
Pattern: Non-Uniform
Stage: TS22
Assay Id: MGI:4450871
Age: embryonic day 14.5
Image: Igfbp2 - E14.5
Note: There is weak staining in the mantle zone of the dorsal thalamus. Staining is either absent or ubiquitous in the mantle zone of the prethalamus.
Detected: true
Specimen Num: 3
GXD Expression  
Probe: MGI:4442777
Assay Type: RNA in situ
Annotation Date: 2010-05-13
Strength: Ambiguous
Sex: Not Specified
Emaps: EMAPS:1754124
Pattern: Not Specified
Stage: TS24
Assay Id: MGI:4450871
Age: embryonic day 16.5
Image: Igfbp2 - E16.5
Note: Staining is either absent or ubiquitous in the mantle zone of the dorsal thalamus and prethalamus.
Specimen Num: 4
Publication  
First Author: Xi G
Year: 2020
Journal: Endocrinology
Title: Estrogen Stimulation of Pleiotrophin Enhances Osteoblast Differentiation and Maintains Bone Mass in IGFBP-2 Null Mice.
Volume: 161
Issue: 4
Publication
First Author: DeMambro VE
Year: 2008
Journal: Endocrinology
Title: Gender-specific changes in bone turnover and skeletal architecture in igfbp-2-null mice.
Volume: 149
Issue: 5
Pages: 2051-61
Publication
First Author: Schwartz DR
Year: 2013
Journal: Endocrinology
Title: Human resistin in chemotherapy-induced heart failure in humanized male mice and in women treated for breast cancer.
Volume: 154
Issue: 11
Pages: 4206-14
Publication
First Author: Xi G
Year: 2013
Journal: Endocrinology
Title: The heparin-binding domains of IGFBP-2 mediate its inhibitory effect on preadipocyte differentiation and fat development in male mice.
Volume: 154
Issue: 11
Pages: 4146-57
Publication
First Author: Shen X
Year: 2012
Journal: Mol Cell Biol
Title: Insulin-like growth factor (IGF) binding protein 2 functions coordinately with receptor protein tyrosine phosphatase β and the IGF-I receptor to regulate IGF-I-stimulated signaling.
Volume: 32
Issue: 20
Pages: 4116-30
Publication
First Author: Xi G
Year: 2016
Journal: Endocrinology
Title: IGF-I and IGFBP-2 Stimulate AMPK Activation and Autophagy, Which Are Required for Osteoblast Differentiation.
Volume: 157
Issue: 1
Pages: 268-81
Publication
First Author: Wood TL
Year: 2000
Journal: Mol Endocrinol
Title: Selective alterations in organ sizes in mice with a targeted disruption of the insulin-like growth factor binding protein-2 gene.
Volume: 14
Issue: 9
Pages: 1472-82
Publication
First Author: Kawai M
Year: 2011
Journal: J Biol Chem
Title: The heparin-binding domain of IGFBP-2 has insulin-like growth factor binding-independent biologic activity in the growing skeleton.
Volume: 286
Issue: 16
Pages: 14670-80
Publication
First Author: Galvan A
Year: 2012
Journal: G3 (Bethesda)
Title: The Lsktm1 locus modulates lung and skin tumorigenesis in the mouse.
Volume: 2
Issue: 9
Pages: 1041-6
Publication
First Author: Hedbacker K
Year: 2010
Journal: Cell Metab
Title: Antidiabetic effects of IGFBP2, a leptin-regulated gene.
Volume: 11
Issue: 1
Pages: 11-22
Publication
First Author: Liu X
Year: 2020
Journal: Am J Physiol Endocrinol Metab
Title: Downregulated microRNA-130b-5p prevents lipid accumulation and insulin resistance in a murine model of nonalcoholic fatty liver disease.
Volume: 319
Issue: 1
Pages: E34-E42
Publication
First Author: Huynh H
Year: 2011
Journal: Blood
Title: IGF binding protein 2 supports the survival and cycling of hematopoietic stem cells.
Volume: 118
Issue: 12
Pages: 3236-43
Publication
First Author: Agarwal N
Year: 1991
Journal: Exp Eye Res
Title: Sequence analysis, expression and chromosomal localization of a gene, isolated from a subtracted human retina cDNA library, that encodes an insulin-like growth factor binding protein (IGFBP2).
Volume: 52
Issue: 5
Pages: 549-61
Publication
First Author: Kou K
Year: 1994
Journal: Genomics
Title: Identification of two clusters of mouse insulin-like growth factor binding protein genes on chromosomes 1 and 11.
Volume: 21
Issue: 3
Pages: 653-5
Publication
First Author: Pais RS
Year: 2013
Journal: PLoS One
Title: Transcriptome analysis in prenatal IGF1-deficient mice identifies molecular pathways and target genes involved in distal lung differentiation.
Volume: 8
Issue: 12
Pages: e83028
Protein Coding Gene
Type: protein_coding_gene
Organism: Mus caroli
Protein Coding Gene
Type: protein_coding_gene
Organism: Mus musculus
Protein Coding Gene
Type: protein_coding_gene
Organism: Mus musculus
Protein Coding Gene
Type: protein_coding_gene
Organism: Mus musculus
Protein Coding Gene
Type: protein_coding_gene
Organism: Mus musculus
Protein Coding Gene
Type: protein_coding_gene
Organism: Mus musculus
Protein Coding Gene
Type: protein_coding_gene
Organism: Mus musculus
Protein Coding Gene
Type: protein_coding_gene
Organism: Mus musculus
Protein Coding Gene
Type: protein_coding_gene
Organism: Mus musculus
Protein Coding Gene
Type: protein_coding_gene
Organism: Mus musculus
Protein Coding Gene
Type: protein_coding_gene
Organism: Mus musculus
Protein Coding Gene
Type: protein_coding_gene
Organism: Mus musculus
Protein Coding Gene
Type: protein_coding_gene
Organism: Mus musculus
Protein Coding Gene
Type: protein_coding_gene
Organism: Mus musculus
Protein Coding Gene
Type: protein_coding_gene
Organism: Mus musculus
Protein Coding Gene
Type: protein_coding_gene
Organism: Mus musculus
Protein Coding Gene
Type: protein_coding_gene
Organism: Mus musculus
Protein Coding Gene
Type: protein_coding_gene
Organism: Mus pahari
Protein Coding Gene
Type: protein_coding_gene
Organism: Mus spretus
Publication
First Author: Landwehr J
Year: 1993
Journal: Gene
Title: Cloning and characterization of the gene encoding murine insulin-like growth factor-binding protein-2, mIGFBP-2.
Volume: 124
Issue: 2
Pages: 281-6
Publication
First Author: Hoeflich A
Year: 1999
Journal: Endocrinology
Title: Overexpression of insulin-like growth factor-binding protein-2 in transgenic mice reduces postnatal body weight gain.
Volume: 140
Issue: 12
Pages: 5488-96
Publication
First Author: Duan C
Year: 1999
Journal: Proc Natl Acad Sci U S A
Title: Insulin-like growth factor binding protein 2 is a growth inhibitory protein conserved in zebrafish.
Volume: 96
Issue: 26
Pages: 15274-9
Publication
First Author: Song S
Year: 1996
Journal: Mol Cell Endocrinol
Title: The unique endometrial expression and genomic organization of the porcine IGFBP-2 gene.
Volume: 120
Issue: 2
Pages: 193-202
Publication
First Author: Hoeflich A
Year: 2002
Journal: FEBS Lett
Title: Mutation of the RGD sequence does not affect plasma membrane association and growth inhibitory effects of elevated IGFBP-2 in vivo.
Volume: 523
Issue: 1-3
Pages: 63-7
Publication
First Author: Hoeflich A
Year: 2004
Journal: Biochem Biophys Res Commun
Title: Peri/nuclear localization of intact insulin-like growth factor binding protein-2 and a distinct carboxyl-terminal IGFBP-2 fragment in vivo.
Volume: 324
Issue: 2
Pages: 705-10
Publication
First Author: Hoeflich A
Year: 2002
Journal: FASEB J
Title: Insulin-like growth factor binding protein 2 (IGFBP-2) separates hypertrophic and hyperplastic effects of growth hormone (GH)/IGF-I excess on adrenocortical cells in vivo.
Volume: 16
Issue: 13
Pages: 1721-31
Publication
First Author: Diehl D
Year: 2009
Journal: Int J Cancer
Title: IGFBP-2 overexpression reduces the appearance of dysplastic aberrant crypt foci and inhibits growth of adenomas in chemically induced colorectal carcinogenesis.
Volume: 124
Issue: 9
Pages: 2220-5
Publication
First Author: Rehfeldt C
Year: 2010
Journal: Am J Physiol Endocrinol Metab
Title: Increased fat mass, decreased myofiber size, and a shift to glycolytic muscle metabolism in adolescent male transgenic mice overexpressing IGFBP-2.
Volume: 299
Issue: 2
Pages: E287-98
Publication
First Author: Kang HS
Year: 2015
Journal: Biochem J
Title: Regulation of IGFBP-2 expression during fasting.
Volume: 467
Issue: 3
Pages: 453-60
Publication
First Author: Reyer A
Year: 2015
Journal: Am J Physiol Endocrinol Metab
Title: The RGD sequence present in IGFBP-2 is required for reduced glucose clearance after oral glucose administration in female transgenic mice.
Volume: 309
Issue: 4
Pages: E409-17
Publication
First Author: Hoeflich A
Year: 2016
Journal: Aging Cell
Title: Dissociation of somatic growth, time of sexual maturity, and life expectancy by overexpression of an RGD-deficient IGFBP-2 variant in female transgenic mice.
Volume: 15
Issue: 1
Pages: 111-7
GXD Expression      
Probe: MGI:21599
Assay Type: Northern blot
Annotation Date: 2004-03-10
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1876728
Stage: TS28
Assay Id: MGI:3029890
Age: postnatal adult
Detected: true
Specimen Num: 5
GXD Expression      
Probe: MGI:21599
Assay Type: Northern blot
Annotation Date: 2004-03-10
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1737328
Stage: TS28
Assay Id: MGI:3029890
Age: postnatal adult
Detected: true
Specimen Num: 2
GXD Expression      
Probe: MGI:1328937
Assay Type: RT-PCR
Annotation Date: 1999-02-16
Strength: Present
Sex: Not Specified
Emaps: EMAPS:318643
Stage: TS03
Assay Id: MGI:1329630
Age: embryonic day 2.0
Detected: true
Specimen Num: 5
GXD Expression        
Probe: MGI:3586501
Assay Type: RT-PCR
Annotation Date: 2005-09-01
Strength: Not Specified
Sex: Not Specified
Emaps: EMAPS:1792123
Stage: TS23
Assay Id: MGI:3586523
Age: embryonic day 15.5
Specimen Num: 4
GXD Expression        
Probe: MGI:3586501
Assay Type: RT-PCR
Annotation Date: 2005-09-01
Strength: Not Specified
Sex: Not Specified
Emaps: EMAPS:1792124
Stage: TS24
Assay Id: MGI:3586523
Age: embryonic day 16.5
Specimen Num: 5
GXD Expression        
Probe: MGI:3586501
Assay Type: RT-PCR
Annotation Date: 2005-09-01
Strength: Not Specified
Sex: Not Specified
Emaps: EMAPS:1792125
Stage: TS25
Assay Id: MGI:3586523
Age: embryonic day 17.5
Specimen Num: 6
GXD Expression        
Probe: MGI:3586501
Assay Type: RT-PCR
Annotation Date: 2005-09-01
Strength: Not Specified
Sex: Not Specified
Emaps: EMAPS:1792126
Stage: TS26
Assay Id: MGI:3586523
Age: embryonic day 18.5
Specimen Num: 7
GXD Expression      
Probe: MGI:1328937
Assay Type: RT-PCR
Annotation Date: 1999-02-16
Strength: Present
Sex: Not Specified
Emaps: EMAPS:160331
Stage: TS01
Assay Id: MGI:1329630
Age: embryonic day 0.5
Detected: true
Specimen Num: 3
GXD Expression      
Probe: MGI:1328937
Assay Type: RT-PCR
Annotation Date: 1999-02-16
Strength: Present
Sex: Not Specified
Emaps: EMAPS:318653
Stage: TS03
Assay Id: MGI:1329630
Age: embryonic day 2.5
Detected: true
Specimen Num: 6